Reports for RANBAXY PHARMACEUTICALS CANADA INC.
Company Name
RANBAXY PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
60 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 60 (100%) | |
Discontinuation Reports |
28 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 28 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
39 (44%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-RANITIDINE | 300MG | TABLET | Resolved | 2017-06-08 | 2018-08-23 | 12310 |
| RAN-RANITIDINE | 300MG | TABLET | Resolved | 2019-07-05 | 2020-08-28 | 88746 |
| RAN-RANITIDINE | 300MG | TABLET | Resolved | 2019-09-23 | 2020-08-28 | 94548 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-07-18 | 2018-08-23 | 16331 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-02-15 | 2020-10-28 | 75900 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132979 |
| RAN-ROPINIROLE | 0.25MG | TABLET | Resolved | 2022-04-12 | 2024-05-09 | 158553 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2017-10-27 | 2018-08-23 | 27310 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2019-02-11 | 2019-07-06 | 75268 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2020-05-27 | 2020-10-28 | 115893 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2022-01-06 | 2022-02-15 | 152163 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2022-08-19 | 2022-11-25 | 167426 |
| RAN-ROPINIROLE | 1.0MG | TABLET | Resolved | 2022-12-13 | 2024-05-09 | 178240 |
| RAN-ROPINIROLE | 2.0MG | TABLET | Resolved | 2019-02-11 | 2019-04-15 | 75271 |
| RAN-ROPINIROLE | 2.0MG | TABLET | Resolved | 2019-05-28 | 2021-01-31 | 85084 |
| RAN-ROPINIROLE | 2.0MG | TABLET | Resolved | 2021-10-21 | 2021-11-26 | 147748 |
| RAN-ROPINIROLE | 2.0MG | TABLET | Resolved | 2022-08-19 | 2024-05-09 | 167429 |
| RAN-ROPINIROLE | 5.0MG | TABLET | Resolved | 2019-02-11 | 2019-04-15 | 75274 |
| RAN-ROPINIROLE | 5.0MG | TABLET | Resolved | 2020-12-03 | 2021-07-13 | 129547 |
| RAN-ROPINIROLE | 5.0MG | TABLET | Resolved | 2022-08-19 | 2024-05-09 | 167432 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-NABILONE | 1MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50986 |
| RAN-NABILONE | 0.25MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50989 |
| RAN-NABILONE | 0.5MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50992 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91278 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91281 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-02-02 | 2020-02-02 | 105096 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-03-07 | 2020-03-07 | 108130 |
| RAN-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-21 | 2017-07-21 | 16588 |